Analyzing the Impact of Lean Approach in Pharmaceutical Supply Chain

2013 ◽  
pp. 253-263 ◽  
Author(s):  
Alberto Portioli Staudacher ◽  
Alice Bush
Keyword(s):  
Supply Chain ◽  
Pharmaceutical Supply Chain ◽  
The Impact

scholarly journals The Impact of Health Policy on The Pharmaceutical Supply Chain In France

2017 ◽  
Vol 20 (9) ◽  
pp. A708
Author(s):  
C Di Martinelly ◽  
C Garonne ◽  
A Duenas
Keyword(s):  
Supply Chain ◽  
Health Policy ◽  
Pharmaceutical Supply Chain ◽  
The Impact

scholarly journals The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol (Preprint)

2020 ◽  
Author(s):  
Madison Milne-Ives ◽  
Ching Lam ◽  
Michelle van Velthoven ◽  
Edward Meinert
Keyword(s):  
United Kingdom ◽  
Supply Chain ◽  
Scoping Review ◽  
Grey Literature ◽  
Healthcare Management ◽  
Risk Of Bias ◽  
Pharmaceutical Supply Chain ◽  
The United Kingdom ◽  
The Uk ◽  
The Impact

BACKGROUND The continuing uncertainty around Brexit has caused concern in the pharmaceutical industry and among health care professionals and patients. The exact consequences of Brexit on the pharmaceutical supply chain in the United Kingdom will depend on whether a deal is reached and what it entails, but it is likely to be affected by the withdrawal of the United Kingdom from the European Union. Regulatory issues and delays in supply have the potential to negatively affect the ability of UK residents to receive an adequate and timely supply of necessary medicines. OBJECTIVE The purpose of this protocol is to provide an overview and critical analysis of current perspectives on the effect of Brexit on the UK pharmaceutical supply chain. METHODS The PRISMA-ScR (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) guidelines will be used to structure this protocol. A systematic search of MEDLINE, EMBASE, PsycINFO, Healthcare Management Information Consortium (HMIC), Cochrane, Web of Science, Business Source Complete, EconLit, and Economist Intelligence Unit will be conducted, as well as a Google and Nexis.UK search for grey literature such as reports, opinion pieces, and press releases. Two reviewers will independently screen the titles and abstracts of identified references and select studies according to the eligibility criteria. Any discrepancies will then be discussed and resolved. One reviewer will extract data from the included studies into a standardized form, which will be validated by a second reviewer. Risk of bias will be assessed using the Cochrane Collaboration Risk of Bias tool for any randomized controlled trials; quality will be assessed using the relevant Critical Appraisal Skills Programme (CASP) checklists; and grey literature will be assessed using the Authority, Accuracy, Coverage, Objectivity, Date, Significance (AACODS) checklist. Outcomes include the agreement between sources on the potential, likelihood, and severity of the consequences of Brexit on the UK pharmaceutical supply chain. RESULTS Results will be included in the scoping review, which will be published in 2020. CONCLUSIONS This scoping review will summarize the currently expected consequences of Brexit on the UK pharmaceutical supply chain. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/17684

Effect of service quality on doctor’s satisfaction and prescribing behavior in pharmaceutical supply chain – a study with reference to a major Indian pharmaceutical company

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Uma Maheswari Devi Parmata ◽  
Surya Prakash Chetla
Keyword(s):  
Supply Chain ◽  
Service Quality ◽  
Pharmaceutical Company ◽  
Three Dimensions ◽  
Pharmaceutical Supply Chain ◽  
Content Type ◽  
Factors Affecting ◽  
Prescribing Behavior ◽  
Quality Scale ◽  
The Impact

Purpose The purpose of this paper is to develop a scale for the measurement of service quality at the manufacturer–doctor interface of the pharmaceutical supply chain and to study the impact of service quality on doctor’s satisfaction and doctor’s prescribing behavior. Doctors from two major states of South India were selected for the study. A doctor perceived service quality scale with three dimensions having eight items was developed through confirmatory factor analysis (CFA) in the pharmaceutical context. Structural equation modeling (SEM) technique was used to show the relationship between service quality, satisfaction and prescribing behavior. The critical factors of service quality were identified, and a model was developed showing the relationship between service quality, doctor’s satisfaction and doctor’s prescribing behavior which has not been explored in any research. This model will be helpful in further development of new concepts and for analyzing the reasons for the failure of doctors in providing quality service.  Design/methodology/approach A total of 200 doctors from three major cities of South India were selected. A doctor perceived service quality scale with three dimensions having eight items was developed through CFA using Parasuraman Service quality scale (Parasuraman, 1985, 1986, 1988) as the basis in the pharmaceutical context after focus group discussions with company experts, retailers, doctors and academicians. SEM technique was used to examine the impact of service quality on doctor’s satisfaction and prescribing behavior. Findings There is no universal set of dimensions and items that determine service quality in manufacturing industries, especially at the manufacturer–doctor interface of the pharmaceutical supply chain though service quality plays a very important role in affecting the performance of manufacturing industries. The critical factors affecting the quality of service for a pharmaceutical company at the manufacturer–doctor interface of the supply chain were identified, and its impact on doctor’s satisfaction and their prescribing behavior were studied. Research limitations/implications This research contributes to the development of service quality scale for measuring service quality in pharmaceutical manufacturing company, especially with reference to manufacturer–doctor interface of the supply chain which was not thoroughly explored earlier. A model was developed showing the positive relationship between service quality and doctor’s satisfaction and doctor’s prescribing behavior in pharmaceutical supply chain which is a new concept not proved experimentally. Practical implications The study is very useful for the pharmaceutical manufacturing companies to identify the service quality factors affecting doctor’s satisfaction and their prescribing behavior thereby leading to development of new measures for improving the performance of the pharmaceutical supply chain. This study can lead to identification of problems involved in pharmaceutical supply chain and also leads to generation of new ideas and development of new concepts for influencing doctor’s satisfaction and doctor’s prescribing behavior which in turn can help in providing better health. Social implications This study actually has a direct impact on the society. If factors affecting doctor’s satisfaction and prescribing behavior are identified automatically, the end consumer, i.e. patient, can be satisfied in a better way, and better medical care can be provided. If doctor’s problems are identified, then better solutions can be provided to patients; this in turn has a lot of positive impact on the pharmaceutical company and society in general. Originality/value This research will act as a base for generating ideas relating to how quality service provided by a company will have an impact on doctor’s satisfaction and his prescribing behavior in pharmaceutical supply chain .To the best of the authors’ knowledge, this study is the first of its kind of the conceptual aspects of service quality, satisfaction and loyalty explained in terms of pharmaceutical supply chain as service quality, doctor’s satisfaction and doctor’s prescribing behavior and proved experimentally.

Advancing the understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Emilia Vann Yaroson ◽  
Liz Breen ◽  
Jiachen Hou ◽  
Julie Sowter
Keyword(s):  
Supply Chain ◽  
Adaptive System ◽  
Complex Adaptive System ◽  
Negative Impact ◽  
Exploratory Research ◽  
Structured Interviews ◽  
Pharmaceutical Supply Chain ◽  
Content Type ◽  
Complex Adaptive ◽  
The Impact

Purpose The purpose of this study was to advance the knowledge of pharmaceutical supply chain (PSC) resilience using complex adaptive system theory (CAS). Design/methodology/approach An exploratory research design, which adopted a qualitative approach was used to achieve the study’s research objective. Qualitative data were gathered through 23 semi-structured interviews with key supply chain actors across the PSC in the UK. Findings The findings demonstrate that CAS, as a theory, provides a systemic approach to understanding PSC resilience by taking into consideration the various elements (environment, PSC characteristics, vulnerabilities and resilience strategies) that make up the entire system. It also provides explanations for key findings, such as the impact of power, conflict and complexity in the PSC, which are influenced by the interactions between supply chain actors and as such increase its susceptibility to the negative impact of disruption. Furthermore, the antecedents for building resilience strategies were the outcome of the decision-making process referred to as co-evolution from a CAS perspective. Originality/value Based on the data collected, the study was able to reflect on the relationships, interactions and interfaces between actors in the PSC using the CAS theory, which supports the proposition that resilience strategies can be adopted by supply chain actors to enhance this service supply chain. This is a novel empirical study of resilience across multiple levels of the PSC and as such adds valuable new knowledge about the phenomenon and the use of CAS theory as a vehicle for exploration and knowledge construction in other supply chains.

scholarly journals Benefit and Challenge of Blockchain Technology in Pharmaceutical Supply Chain Management

2019 ◽  
Vol 8 (4) ◽  
pp. 8309-8313
Keyword(s):  
Supply Chain ◽  
Supply Chain Management ◽  
Pharmaceutical Industry ◽  
Innovative Technology ◽  
Financial Industry ◽  
Pharmaceutical Supply Chain ◽  
Chain Management ◽  
Counterfeit Drug ◽  
Blockchain Technology ◽  
The Impact

Pharmaceutical Industry Supply Chain Management (SCM) has been an invigorating research topic because the industry strives to explore innovative ways to secure the medicine distribution and to ensure the authenticity of medicine consumed by the patients. A surge in the counterfeit drug has called an urgent effort for the industry to eradicate. In this scope, the fake medicine harm serious health problem for patients. To cope with this urgency, Blockchain offers the new innovative technology that captures the security and accountability in the financial industry for decades. In this spectrum, the new generation of blockchain with smart contract feature enables the utilization of blockchain in an enterprise setting such as Supply Chain Management Systems. In this point, this study explored contemporary for benefit and challenge blockchain adoption based on Systematic Literature Review methodology. At a closer look, the research indicates the impact of the Blockchain Adoption Technology in Pharmaceutical Industry SCM in for four aspects, i.e. supplier, producer, logistic/distributor, and customer. In a specific range, this research explores significant factors from ten leading journals (one thousand two hundred and fourteen papers) and selects solely eighteen relevant documents. The examination reveals the critical research development of blockchain technology adoption in Pharmaceutical SCM and twenty-three essential factors.

scholarly journals THE IMPACT OF THE EUROPEAN DIRECTIVE AGAINST FALSIFIED MEDICINES ON THE PHARMACEUTICAL WHOLESALERS IN BULGARIA

2021 ◽  
Vol 27 (1) ◽  
pp. 3598-3603
Author(s):  
Krasimira Valcheva ◽  
Keyword(s):  
Supply Chain ◽  
The European Union ◽  
Pharmaceutical Supply Chain ◽  
Health Authorities ◽  
European System ◽  
Falsified Medicines ◽  
Verification Process ◽  
One Year ◽  
Global Threat ◽  
The Impact

In the last few decades, the problem with falsified medicine became a global threat that accounts for millions of human lives and billions of financial loses for the national health authorities and pharmaceutical industry. Different measures were developed to fight their uncontrolled spread but had only limited success. The resolution that united the pharmaceutical supply chain actors worldwide is the introduction of track-and-trace systems, based on product serialization and verification. The European Union also adopted this solution, and its official operation began in 2019. Each Member State has specifics that have to be accounted for in the national transposition process and should influence the system design and functionalities. In Bulgaria, the responsible authorities seriously delayed to adopt an adequate legal and regulatory framework to support its smooth operation. This created many problems for some of the key supply chain participants – the wholesalers. Since the European system is not a full track-and-trace solution, their role in the verification process is limited and left to the national authorities to decide how to regulate it. At present, more than one year after the launch of the system, the national bylaws that should regulate their activities with reference to the European policy are still not enforced. The wholesalers are left to align their operations in a regulatory vacuum that may compromise the effectiveness of the policy and lead to sanctions for noncompliance.

scholarly journals Influence of Supply Chain Management Strategies on Performance of Medical Supply Chain Organisations in Kenya

2021 ◽  
Vol 3 (3) ◽  
pp. 32-51
Author(s):  
Peter Mwangi Njuguna ◽  
Wycliffe Arani ◽  
Viginia Onyara
Keyword(s):  
Supply Chain ◽  
Supply Chain Management ◽  
Information Integration ◽  
Management Strategies ◽  
Negative Influence ◽  
Pharmaceutical Supply Chain ◽  
Chain Management ◽  
Medical Supply ◽  
The Impact ◽  
Lean Supply Chain

Institutions within the medical supply sector have consistently faced substandard supply chain results because of failure of timely deliveries on the part of suppliers failing to quickly respond to deliver medical shipments. This indicates the procurement role having inadequacies as a key component of an organization since it does not deliver on maximized effectiveness and a reduction of costs based on poor supply chain management plans. A critical purpose of the study was the intention to identify influence of supply chain management strategies on performance of medical supply chain organisations in Kenya. More so, the analysis deals with the degree information integration impacts on Organization performance; to evaluate the impact of warehousing on performance; to examine the impact of outsourcing on performance; and to evaluate the influence of lean supply chain on performance of medical supply entities across Kenya. Direction will through be relying on the resource-based theory as well as the supply chain constraints principle. The analysis will adopt a descriptive study approach; with the targeted size comprising of 30 medical supply entities. The study participants included 2,529 staff of pharmaceutical supply chain entities within Kenya. Determination of the sample group was by Yamane’s concept that led to to a group of 345 participants. Accessing the participants was by stratified and simple random sampling approaches. Towards indicating dispersion and central tendency, standard deviation and respectively, with the inferential statistics being analysed by multiple regression and correlation analysis. The study findings reveal that performance of medical supply organizations in Kenya was significantly related with supply chain information integration (p < 0.05), warehousing (p < 0.05) and outsourcing. Despite this, the association among differentiation strategy and performance was insignificant at p > 0.05 but only significant at p <0.1). It was also found that while lean supply chain had a negative influence on performance (t = -.528, p >0.5) information integration, warehousing and outsourcing had positive influence on performance (information integration: t = 16.461, p <0.05; warehousing: t = 19.671, p <0.05; outsourcing: t = 15.528, p <0.05). The result of these outcomes is that the leadership across medical supply organizations in Kenya need to adopt information integration, warehousing, and outsourcing, which would   positively contribute to performance. Medical supply organizations in Kenya should continue emphasizing on supply chain strategies. The outcomes of the study may assist organisations in drawing plans or improving existing strategies governing supply chain management across institutions.

Sign in / Sign up

Export Citation Format

Share Document